News
Radar
Home
Research
Products & Services
Online Data Service
Deals in Europe Report
Radar
Advanced Search
Add Company
Add Person
Customized Research
Weekly Newsletter
Online News
Events
Arakis (Acquired by Sosei Co. Ltd.)
The company develop and commercialise innovative market orientated pharmaceutical products .
• Show past press releases
• Edit this company
CONTACT INFORMATION
Address:
Phone:
Fax:
Web:
Contact:
Chesterford Research Park
Little Chesterford
Saffron Walden CB10 1XL
United Kingdom
+44 (0)1799 532350
+44 (0)1799 532351
http://www.arakis.com
Dr Ken Cunningham
+44 (0)1799 532352
COMPANY FACTS
Founded:
Dec 2000
Founders:
Dr Ken Cunningham
CEO:
Dr Ken Cunningham
CTO or technical lead:
Robin Bannister
CFO or finance director:
Peter Keen
Head of Sales:
Julian Gilbert
Head of Marketing:
Stage:
Startup
Category:
Biotechnology & Healthcare
Sector:
Biopharmaceuticals
Employees:
35
Profitability:
Pre-revenue
Funding raised:
Yes
Funding sought:
Yes
Seeking Partnerships:
NON-EXECUTIVE BOARD MEMBERS
Mr Michael Redmond
Dr Andy Richards
Dr Brian Gennery
Dr John Gonzalez
Mr Peter Keen
Brian Kerr ,
Scottish Equity Partners Limited (SEP)
Martin Edwards,
Novo A/S
KEY CUSTOMERS
KEY BUSINESS PARTNERS
Penwest Pharmaceuticals - co-development alliance AD 121
Vectura Limited - co-development alliance AD 237
KS Biomedix Holdings PLC- co-development alliance AD 452 & KSB 307
SkyePharma PLC - co-development alliance AD 313
Penwest Pharmaceuticals - creation and development alliance in pain
Penwest Pharmaceuticals - creation and development alliance in pain
Vectura Limited - co-development alliance AD 237
KS Biomedix Holdings PLC- co-development alliance AD 452 & KSB 307
SkyePharma PLC - co-development alliance AD 313
Penwest Pharmaceuticals - creation and development alliance in pain
KEY COMPETITORS
CAPITAL RAISED
Date
Size
Investors
To view this information you must be signed in and subscribed to the online dataservice,
sign in
here.
To read more about the Online data service
click here
PUBLIC OFFERINGS
Date
Type
Exchange
No public offerings
Copyright © 1999-2010
Test Publishing Limited
. All rights reserved.
Legal Information
.